메뉴 건너뛰기




Volumn 45, Issue 2, 2017, Pages 193-204

Systematic review with meta-analysis: the comparative effectiveness of aspirin vs. screening for colorectal cancer prevention

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; GUAIAC;

EID: 85002194712     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13857     Document Type: Review
Times cited : (33)

References (46)
  • 1
    • 84890939875 scopus 로고    scopus 로고
    • Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals
    • Holme O, Bretthauer M, Fretheim A, Odgaard-Jensen J, Hoff G. Flexible sigmoidoscopy versus faecal occult blood testing for colorectal cancer screening in asymptomatic individuals. Cochrane Database Syst Rev 2013; 9: CD009259.
    • (2013) Cochrane Database Syst Rev , vol.9 , pp. CD009259
    • Holme, O.1    Bretthauer, M.2    Fretheim, A.3    Odgaard-Jensen, J.4    Hoff, G.5
  • 2
    • 84885136577 scopus 로고    scopus 로고
    • Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews
    • Sutcliffe P, Connock M, Gurung T, et al. Aspirin for prophylactic use in the primary prevention of cardiovascular disease and cancer: a systematic review and overview of reviews. Health Technol Assess 2013; 17: 1–253.
    • (2013) Health Technol Assess , vol.17 , pp. 1-253
    • Sutcliffe, P.1    Connock, M.2    Gurung, T.3
  • 3
    • 84863726621 scopus 로고    scopus 로고
    • Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis
    • Hassan C, Rex DK, Cooper GS, Zullo A, Launois R, Benamouzig R. Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis. Gut 2011; 61: 1172–9.
    • (2011) Gut , vol.61 , pp. 1172-1179
    • Hassan, C.1    Rex, D.K.2    Cooper, G.S.3    Zullo, A.4    Launois, R.5    Benamouzig, R.6
  • 5
    • 68049122102 scopus 로고    scopus 로고
    • Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
    • Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.
    • (2009) PLoS Med , vol.6
    • Moher, D.1    Liberati, A.2    Tetzlaff, J.3    Altman, D.G.4
  • 6
    • 84932084410 scopus 로고    scopus 로고
    • The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations
    • Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 2015; 162: 777–84.
    • (2015) Ann Intern Med , vol.162 , pp. 777-784
    • Hutton, B.1    Salanti, G.2    Caldwell, D.M.3
  • 7
    • 78650215449 scopus 로고    scopus 로고
    • Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
    • Rothwell PM, Wilson M, Elwin CE, et al. Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet 2010; 376: 1741–50.
    • (2010) Lancet , vol.376 , pp. 1741-1750
    • Rothwell, P.M.1    Wilson, M.2    Elwin, C.E.3
  • 8
    • 42949127635 scopus 로고    scopus 로고
    • Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
    • Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134: 1570–95.
    • (2008) Gastroenterology , vol.134 , pp. 1570-1595
    • Levin, B.1    Lieberman, D.A.2    McFarland, B.3
  • 9
    • 0026355123 scopus 로고
    • The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results
    • Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991; 54: 1044–54.
    • (1991) J Neurol Neurosurg Psychiatry , vol.54 , pp. 1044-1054
    • Farrell, B.1    Godwin, J.2    Richards, S.3    Warlow, C.4
  • 10
    • 0032562005 scopus 로고    scopus 로고
    • Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework
    • Thrombosis prevention trial: randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk. The Medical Research Council's General Practice Research Framework. Lancet 1998; 351: 233–41.
    • (1998) Lancet , vol.351 , pp. 233-241
  • 11
    • 0023845856 scopus 로고
    • Randomised trial of prophylactic daily aspirin in British male doctors
    • Peto R, Gray R, Collins R, et al. Randomised trial of prophylactic daily aspirin in British male doctors. Br Med J (Clin Res Ed) 1988; 296: 313–6.
    • (1988) Br Med J (Clin Res Ed) , vol.296 , pp. 313-316
    • Peto, R.1    Gray, R.2    Collins, R.3
  • 12
    • 0025751563 scopus 로고
    • Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. The SALT Collaborative Group
    • Swedish Aspirin Low-Dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. The SALT Collaborative Group. Lancet 1991; 338: 1345–9.
    • (1991) Lancet , vol.338 , pp. 1345-1349
  • 13
    • 34248157118 scopus 로고    scopus 로고
    • Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies
    • Flossmann E, Rothwell PM. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies. Lancet 2007; 369: 1603–13.
    • (2007) Lancet , vol.369 , pp. 1603-1613
    • Flossmann, E.1    Rothwell, P.M.2
  • 15
    • 84880278340 scopus 로고    scopus 로고
    • Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial
    • Cook NR, Lee IM, Zhang SM, Moorthy MV, Buring JE. Alternate-day, low-dose aspirin and cancer risk: long-term observational follow-up of a randomized trial. Ann Intern Med 2013; 159: 77–85.
    • (2013) Ann Intern Med , vol.159 , pp. 77-85
    • Cook, N.R.1    Lee, I.M.2    Zhang, S.M.3    Moorthy, M.V.4    Buring, J.E.5
  • 20
    • 84875612338 scopus 로고    scopus 로고
    • Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression
    • White IR, Barrett JK, Jackson D, Higgins JP. Consistency and inconsistency in network meta-analysis: model estimation using multivariate meta-regression. Res Synth Methods 2012; 3: 111–25.
    • (2012) Res Synth Methods , vol.3 , pp. 111-125
    • White, I.R.1    Barrett, J.K.2    Jackson, D.3    Higgins, J.P.4
  • 21
    • 68149160854 scopus 로고    scopus 로고
    • Multivariate random-effects meta-analysis
    • White IR. Multivariate random-effects meta-analysis. Stata J 2009; 9: 40–56.
    • (2009) Stata J , vol.9 , pp. 40-56
    • White, I.R.1
  • 22
    • 79960824714 scopus 로고    scopus 로고
    • Multivariate random-effects meta-regression: Updates to mvmeta
    • White IR. Multivariate random-effects meta-regression: Updates to mvmeta. Stata J 2011; 11: 255–70.
    • (2011) Stata J , vol.11 , pp. 255-270
    • White, I.R.1
  • 24
    • 84899557077 scopus 로고    scopus 로고
    • Characteristics of networks of interventions: a description of a database of 186 published networks
    • [Electronic Resource]
    • Nikolakopoulou A, Chaimani A, Veroniki AA, Vasiliadis HS, Schmid CH, Salanti G. Characteristics of networks of interventions: a description of a database of 186 published networks. PLoS ONE [Electronic Resource] 2014; 9: e86754.
    • (2014) PLoS ONE , vol.9
    • Nikolakopoulou, A.1    Chaimani, A.2    Veroniki, A.A.3    Vasiliadis, H.S.4    Schmid, C.H.5    Salanti, G.6
  • 26
    • 80052676840 scopus 로고    scopus 로고
    • Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian randomized controlled trial—SCORE
    • Segnan N, Armaroli P, Bonelli L, et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian randomized controlled trial—SCORE. J Natl Cancer Inst 2011; 103: 1310–22.
    • (2011) J Natl Cancer Inst , vol.103 , pp. 1310-1322
    • Segnan, N.1    Armaroli, P.2    Bonelli, L.3
  • 27
    • 84861573867 scopus 로고    scopus 로고
    • Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up
    • Scholefield JH, Moss SM, Mangham CM, Whynes DK, Hardcastle JD. Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up. Gut 2012; 61: 1036–40.
    • (2012) Gut , vol.61 , pp. 1036-1040
    • Scholefield, J.H.1    Moss, S.M.2    Mangham, C.M.3    Whynes, D.K.4    Hardcastle, J.D.5
  • 28
    • 84862583882 scopus 로고    scopus 로고
    • Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy
    • Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 2012; 366: 2345–57.
    • (2012) N Engl J Med , vol.366 , pp. 2345-2357
    • Schoen, R.E.1    Pinsky, P.F.2    Weissfeld, J.L.3
  • 29
    • 84975730903 scopus 로고    scopus 로고
    • Screening for Colorectal cancer: updated evidence report and systematic review for the US preventive services task force
    • Lin JS, Piper MA, Perdue LA, et al. Screening for Colorectal cancer: updated evidence report and systematic review for the US preventive services task force. JAMA 2016; 315: 2576–94.
    • (2016) JAMA , vol.315 , pp. 2576-2594
    • Lin, J.S.1    Piper, M.A.2    Perdue, L.A.3
  • 31
    • 84941346697 scopus 로고    scopus 로고
    • Aspirin for primary prevention of cardiovascular disease and cancer. A benefit and harm analysis
    • Stegeman I, Bossuyt PM, Yu T, Boyd C, Puhan MA. Aspirin for primary prevention of cardiovascular disease and cancer. A benefit and harm analysis. PLoS ONE 2015; 10: e0127194.
    • (2015) PLoS ONE , vol.10
    • Stegeman, I.1    Bossuyt, P.M.2    Yu, T.3    Boyd, C.4    Puhan, M.A.5
  • 32
    • 84922908649 scopus 로고    scopus 로고
    • Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women
    • Van Kruijsdijk RCM, Visseren FLJ, Ridker PM, et al. Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women. Heart 2015; 101: 369–76.
    • (2015) Heart , vol.101 , pp. 369-376
    • Van Kruijsdijk, R.C.M.1    Visseren, F.L.J.2    Ridker, P.M.3
  • 33
    • 84942597080 scopus 로고    scopus 로고
    • Benefit-harm analysis and charts for individualized and preference-sensitive prevention: example of low dose aspirin for primary prevention of cardiovascular disease and cancer
    • Puhan MA, Yu T, Stegeman I, Varadhan R, Singh S, Boyd CM. Benefit-harm analysis and charts for individualized and preference-sensitive prevention: example of low dose aspirin for primary prevention of cardiovascular disease and cancer. BMC Med 2015; 13: 250.
    • (2015) BMC Med , vol.13 , pp. 250
    • Puhan, M.A.1    Yu, T.2    Stegeman, I.3    Varadhan, R.4    Singh, S.5    Boyd, C.M.6
  • 34
    • 84940381575 scopus 로고    scopus 로고
    • Long-term lifestyle changes after colorectal cancer screening: randomised controlled trial
    • Berstad P, Loberg M, Larsen IK, et al. Long-term lifestyle changes after colorectal cancer screening: randomised controlled trial. Gut 2015; 64: 1268–76.
    • (2015) Gut , vol.64 , pp. 1268-1276
    • Berstad, P.1    Loberg, M.2    Larsen, I.K.3
  • 35
    • 78650825618 scopus 로고    scopus 로고
    • Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
    • Rothwell PM, Fowkes FG, Belch JF, Ogawa H, Warlow CP, Meade TW. Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet 2011; 377: 31–41.
    • (2011) Lancet , vol.377 , pp. 31-41
    • Rothwell, P.M.1    Fowkes, F.G.2    Belch, J.F.3    Ogawa, H.4    Warlow, C.P.5    Meade, T.W.6
  • 36
    • 84860467522 scopus 로고    scopus 로고
    • Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials
    • Algra AM, Rothwell PM. Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials. Lancet Oncol 2012; 13: 518–27.
    • (2012) Lancet Oncol , vol.13 , pp. 518-527
    • Algra, A.M.1    Rothwell, P.M.2
  • 37
    • 85006220619 scopus 로고    scopus 로고
    • Long-term effectiveness of endoscopic screening on incidence and mortality of colorectal cancer: a randomized trial
    • Thiis-Evensen E, Kalager M, Bretthauer M, Hoff G. Long-term effectiveness of endoscopic screening on incidence and mortality of colorectal cancer: a randomized trial. United European Gastroenterol J 2013; 1: 162–8.
    • (2013) United European Gastroenterol J , vol.1 , pp. 162-168
    • Thiis-Evensen, E.1    Kalager, M.2    Bretthauer, M.3    Hoff, G.4
  • 38
    • 84905901559 scopus 로고    scopus 로고
    • Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial
    • Holme O, Loberg M, Kalager M, et al. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. JAMA 2014; 312: 606–15.
    • (2014) JAMA , vol.312 , pp. 606-615
    • Holme, O.1    Loberg, M.2    Kalager, M.3
  • 39
    • 77951879165 scopus 로고    scopus 로고
    • Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial
    • Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010; 375: 1624–33.
    • (2010) Lancet , vol.375 , pp. 1624-1633
    • Atkin, W.S.1    Edwards, R.2    Kralj-Hans, I.3
  • 40
    • 0034735826 scopus 로고    scopus 로고
    • The effect of fecal occult-blood screening on the incidence of colorectal cancer
    • Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med 2000; 343: 1603–7.
    • (2000) N Engl J Med , vol.343 , pp. 1603-1607
    • Mandel, J.S.1    Church, T.R.2    Bond, J.H.3
  • 41
    • 84884183059 scopus 로고    scopus 로고
    • Long-term mortality after screening for colorectal cancer
    • Shaukat A, Mongin SJ, Geisser MS, et al. Long-term mortality after screening for colorectal cancer. N Engl J Med 2013; 369: 1106–14.
    • (2013) N Engl J Med , vol.369 , pp. 1106-1114
    • Shaukat, A.1    Mongin, S.J.2    Geisser, M.S.3
  • 42
    • 48249127689 scopus 로고    scopus 로고
    • Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer
    • Lindholm E, Brevinge H, Haglind E. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg 2008; 95: 1029–36.
    • (2008) Br J Surg , vol.95 , pp. 1029-1036
    • Lindholm, E.1    Brevinge, H.2    Haglind, E.3
  • 43
    • 4544310710 scopus 로고    scopus 로고
    • Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds
    • Kronborg O, Jørgensen OD, Fenger C, Rasmussen M. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol 2004; 39: 846–51.
    • (2004) Scand J Gastroenterol , vol.39 , pp. 846-851
    • Kronborg, O.1    Jørgensen, O.D.2    Fenger, C.3    Rasmussen, M.4
  • 45
    • 21444450527 scopus 로고    scopus 로고
    • Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial
    • Cook NR, Lee IM, Gaziano JM, et al. Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005; 294: 47–55.
    • (2005) JAMA , vol.294 , pp. 47-55
    • Cook, N.R.1    Lee, I.M.2    Gaziano, J.M.3
  • 46
    • 0024298599 scopus 로고
    • Findings from the aspirin component of the ongoing Physicians’ Health Study
    • Findings from the aspirin component of the ongoing Physicians’ Health Study. N Engl J Med 1988; 318: 262–4.
    • (1988) N Engl J Med , vol.318 , pp. 262-264


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.